A dangerous drug-resistant superbug is surging in European hospitals, spreading between patients and becoming increasingly harder to treat, the EU’s disease agency warns. Cases of bloodstream infections caused by treatment-resistant Klebsiella pneumoniae have increased by 72% between 2019 and 2025 — way off a target of cutting rates by 5% by 2030 — according to the latest bundle of reports from the European Centre for Disease Prevention and Control, out Wednesday. Infections linked to this bacterium, which have been climbing steadily for the past few years , are a significant threat to patients in hospitals and have a high mortality rate typically between 40% and 70%.
We show the main point publicly. Create a free account to continue reading the full article, save it, discuss it, and connect it with market and OSINT context.
